XADAGO/EQUFINA: Transforming the Landscape of Parkinson's Disease Treatment
Revolutionizing Parkinson's Disease Treatment: XADAGO/EQUFINA
Introduction
XADAGO, known as EQUFINA in Japan, represents a significant advancement in the treatment of Parkinson's disease. This selective monoamine oxidase B (MAO-B) inhibitor provides an innovative mechanism to improve motor function and extend
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.